Sangi's R&D focuses mainly on consumer oral care, but progress is also advanced in a number of fields.
Other applications for hydroxyapatite currently under development include
|
|
| •
|
A home-care anticaries system targeting oral mutans streptococci reduction (3DS), in conjunction with the Japanese National Institute of Infectious Diseases
|
|
| •
|
Fine-particle hydroxyapatite for a powder jet deposition system of treating tooth decay (PJD), in conjunction with Tohoku University and Sendai Nikon
|
|
| •
|
Drug delivery agents for anticancer therapy (DDS), in conjuction with Chiba University and the Japanese International Medical Center
|
|
| •
|
Catalysts for converting plant-derived ethanol into gasoline and other industrial chemicals, avoiding recourse to fossil fuels ('Green Ethanol Chemistry'), under a grant from the Japan New Energy Development Organization (NEDO). |
